3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Solid Tumors
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharangeal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Kidney Neoplasms
1
Kidney Diseases
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Diffuse Intrinsic Pontine Glioma
1
CRC
1
Interventions
Azacitidine
12
Cyclophosphamide
10
venetoclax
8
fludarabine phosphate
7
fludarabine
7
Whole-Body Irradiation
7
Biopsy
7
Specimen Handling
6
Mycophenolic Acid
6
Injections
6
Decitabine
6
Tacrolimus
5
Cytarabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporine
4
cedazuridine
3
X-Rays
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
olutasidenib
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Idarubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
spartalizumab
×
90 days
×
Clear all
No trials found.